This Valentine’s Day, How To Revive A ‘Dead Bedroom’

Valentine’s Day may be Valen-time to address any “dead bedroom” in a relationship, meaning low sex frequency or other lack of physical intimacy. Here’s how to do that.

2026 Winter Olympics Village Ran Out Of Condoms After Just 3 Days

Some International Condom Day news: the Olympic Village at Milan Cortina, Italy, the site of the 2026 Winter Olympics ran out of free condoms within just three days.

2M+ Raised After James Van Der Beek’s Death Sparks Medical Debt Debate

Physician expert, Nishant Uppal speaks about the complexity of medical billing in the wake of James Van Der Beek’s death and GoFundMe launch.

Call Doctors Physicians, Not “Providers,” Specialty Group Says

A new ACP policy paper says physicians should not be called providers. The term undermines professionalism, ethics, and trust, according to ACP.

Why Breaking Up Health Insurer Conglomerates May Be Difficult

Senators Hawley and Warren want to break up vertically integrated healthcare conglomerates. History shows, however, how hard a task this will be to accomplish.

Chikungunya Outbreak In Seychelles. What’s Missing From CDC Warning

If you are traveling to the Seychelles, pay attention to the CDC warning of chikungunya outbreak there. Even if you are not, here’s what the warning may say about the CDC

Startup Organotics Fast Tracks Personalized Brain Drug Trials

Organotics, a brain organoid startup, uses AI and patient-derived brain models to fast-track personalized medicine for autism and reduce psychiatric drug failure.

New Study Looks At Young Adolescents Who Own Smartphones

A recent study analyzed the likelihood of young children receiving their owns smartphone, often before fourth grade.

This Startup Is Boosting AI With Real Brain Cells

Training AI models using neurons. Getting hydrogen energy from water using sunlight. Elon Musk’s pivot to the Moon. All that and more in this week’s edition of the Prototype.

HHS Casts Doubts On mRNA Products, But Funds Studies On Debunked Theories

It’s conspicuous that HHS refuses to review Moderna’s application for regulatory approval of an mRNA-based flu vaccine while it prioritizes research on debunked theories.